Anthony P Goldstone
Overview
Explore the profile of Anthony P Goldstone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
2181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heymsfield S, Clement K, Dubern B, Goldstone A, Haqq A, Kuhnen P, et al.
Curr Obes Rep
. 2025 Mar;
14(1):23.
PMID: 40067578
No abstract available.
2.
Heymsfield S, Clement K, Dubern B, Goldstone A, Haqq A, Kuhnen P, et al.
Curr Obes Rep
. 2025 Jan;
14(1):13.
PMID: 39856371
Purpose Of Review: Hyperphagia is a condition associated with rare obesity-related diseases, presenting as a pathologic, insatiable hunger accompanied by abnormal food-seeking behaviors. In October 2023, a group of researchers...
3.
Emini M, Bhargava R, Aldhwayan M, Chhina N, Rodriguez Flores M, Aldubaikhi G, et al.
J Endocr Soc
. 2024 Dec;
9(1):bvae214.
PMID: 39659543
Context: The liver/foregut satiety hormone liver-expressed antimicrobial peptide 2 (LEAP2) is an inverse agonist at the acyl ghrelin receptor (GHSR), increasing after food intake and decreasing after bariatric surgery and...
4.
Shaikh M, Barrett T, Bridges N, Chung R, Gevers E, Goldstone A, et al.
Endocr Connect
. 2024 Jun;
13(8).
PMID: 38838713
Prader-Willi syndrome (PWS) is a rare orphan disease and complex genetic neurodevelopmental disorder, with a birth incidence of approximately 1 in 10,000-30,000. Management of people with PWS requires a multi-disciplinary...
5.
Hughes B, Holland A, Hodebeck-Stuntebeck N, Garrick L, Goldstone A, Lister M, et al.
Orphanet J Rare Dis
. 2024 Feb;
19(1):48.
PMID: 38326873
Background: Prader-Willi syndrome (PWS) is a complex genetic neurodevelopmental condition characterised by a range of debilitating and lifelong symptoms. The many physical and behavioural challenges that arise with adults with...
6.
Alabdulkader S, Al-Alsheikh A, Miras A, Goldstone A
Neuroimage Clin
. 2024 Jan;
41:103563.
PMID: 38237270
Changes in eating behaviour including reductions in appetite and food intake, and healthier food cue reactivity, reward, hedonics and potentially also preference, contribute to weight loss and its health benefits...
7.
Miller J, Gevers E, Bridges N, Yanovski J, Salehi P, Obrynba K, et al.
Obesity (Silver Spring)
. 2023 Nov;
32(2):252-261.
PMID: 37919617
Objective: This study assessed the effect of 1-year administration of diazoxide choline extended-release tablet (DCCR) on hyperphagia and other complications of Prader-Willi syndrome (PWS). Methods: The authors studied 125 participants...
8.
Al-Alsheikh A, Alabdulkader S, Miras A, Goldstone A
Obes Rev
. 2023 Sep;
24(11):e13620.
PMID: 37699864
This systematic review collates studies of dietary or bariatric surgery interventions for obesity using positron emission tomography and single-photon emission computed tomography. Of 604 publications identified, 22 met inclusion criteria....
9.
Howell T, Matza L, Mallya U, Goldstone A, Butsch W, Lazarus E
Obes Sci Pract
. 2023 Aug;
9(4):376-382.
PMID: 37546284
Objective: Rare genetic diseases of obesity typically present with hyperphagia, a pathologic desire to consume food. Cost-utility models assessing the value of treatments for these rare diseases will require health...
10.
Bhargava R, Luur S, Rodriguez Flores M, Emini M, Prechtl C, Goldstone A
J Endocr Soc
. 2023 Jun;
7(7):bvad061.
PMID: 37287649
Background: The novel liver-gut hormone liver-expressed antimicrobial peptide-2 (LEAP2) is a centrally acting inverse agonist, and competitive antagonist of orexigenic acyl ghrelin (AG), at the GH secretagogue receptor, reducing food...